Home | Metabolism | Phenylketonuria (PKU) | Congress activities | Society for Inherited Metabolic Disorders (SIMD)

Society for Inherited Metabolic Disorders (SIMD)

View all GMDI SSIEM SIMD

The Society for Inherited Metabolic Disorders (SIMD) meets annually to generate meaningful discussions between clinicians and investigators on inborn errors of metabolism to facilitate collaboration. It fosters clinical research in the biochemical and molecular basis of normal and metabolic disorders to raise awareness of these rare conditions.

Please select the resource of interest below:

Society for Inherited Metabolic Disorders (SIMD)
SIMD 2024 poster: Preliminary results from the ongoing APHENITY extension study: Sepiapterin reduces blood Phe with improved dietary Phe tolerance in participants with phenylketonuria
This poster, presented at SIMD 2024, discusses the preliminary results from the ongoing APHENITY extension study, which evaluates the safety of sepiapterin and its effect on dietary phenylalanine (Phe) consumption in participants with phenylketonuria (PKU)
Year
Topic
Therapy area
Congress
Type
MED-ALL-PKU-2300101 | April 2024
Sign in or register to access exclusive content on this site 
  REGISTER

Welcome to MEDhub

A website for healthcare professionals, provided by PTC Therapeutics

This educational website provides you with the latest scientific data and expert
insights on the diagnosis and management of a range of rare diseases across the neuromuscular system, central nervous system, and other areas

This content is protected. To view it please enter your email address below:

Register here to access the content on the site
MED-ALL-CORP-2200029 | October 2023

COMING SOON

The content you are trying to access is not currently available.

We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.